Universal Ibogaine Inc. (TSXV: IBO)

๐Ÿ“ Vancouver, Canada๐Ÿ—“ Founded 2018๐Ÿ‘ฅ 7 employees๐Ÿ’ฐ Last funded Sep 2018
Ibogaine is a plant derived neuroactive compound that appears to reset the brains of drug dependent individuals to a pre-addicted state. Ibogaine has demonstrated particular effectiveness in treating opioid use disorder. When applied according to a strict safety protocol, ibogaine appears to eliminate the most painful symptoms of opioid withdrawal and provides a several month window free of drug cravings. Dr Alberto Sola, co-founder of Universal Ibogaine has administered more ibogaine treatments than any other doctor in the world. Universal Ibogaine is a life sciences company, with a mission to demonstrate the safety and efficacy of its ibogaine based drug detox protocol through a Canadian Clinical Trial, and ultimately to utilize that protocol around the globe through future licensing agreements. UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Clinic that, when paired with the ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Universal Ibogaine Inc. (TSXV: IBO)?
Universal Ibogaine Inc. (TSXV: IBO) has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Universal Ibogaine Inc. (TSXV: IBO) last raise funding?
The most recent investment in Universal Ibogaine Inc. (TSXV: IBO) recorded on gritt.io was in September 2018.
When was Universal Ibogaine Inc. (TSXV: IBO) founded?
Universal Ibogaine Inc. (TSXV: IBO) was founded in 2018.
What industry is Universal Ibogaine Inc. (TSXV: IBO) in?
Universal Ibogaine Inc. (TSXV: IBO) operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Universal Ibogaine Inc. (TSXV: IBO) based?
Universal Ibogaine Inc. (TSXV: IBO) is headquartered in Vancouver, Canada.